In vivo angiogenesis imaging of solid tumors by alpha(v)beta(3)-targeted, dual-modality micellar nanoprobes (Q42957543)

11 November 2017

In vivo angiogenesis imaging of solid tumors by alpha(v)beta(3)-targeted, dual-modality micellar nanoprobes (English)

1 reference

11 November 2017

Chase W Kessinger

1

1 reference

11 November 2017

Chalermchai Khemtong

2

1 reference

11 November 2017

Osamu Togao

3

1 reference

11 November 2017

Masaya Takahashi

4

1 reference

11 November 2017

Baran D Sumer

5

1 reference

11 November 2017

Jinming Gao

6

1 reference

11 November 2017

1 August 2010

1 reference

Experimental Biology and Medicine

11 November 2017

1 reference

11 November 2017

235

1 reference

11 November 2017

8

1 reference

11 November 2017

957-965

1 reference

Relationship between vascularity, age and survival in non-small-cell lung cancer

11 November 2017

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010096

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010096

DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010096

MR molecular imaging of the Her-2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010096

Folate-conjugated iron oxide nanoparticles for solid tumor targeting as potential specific magnetic hyperthermia mediators: synthesis, physicochemical characterization, and in vitro experiments

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010096

The transferrin receptor: a potential molecular imaging marker for human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010096

Paramagnetic lipid-coated silica nanoparticles with a fluorescent quantum dot core: a new contrast agent platform for multimodality imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010096

Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010096

Multimodality molecular imaging of tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010096

In vivo off-resonance saturation magnetic resonance imaging of alphavbeta3-targeted superparamagnetic nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010096

Requirement of vascular integrin alpha v beta 3 for angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010096

Tumor angiogenesis correlates with metastatic disease, N-myc amplification, and poor outcome in human neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010096

Angiogenesis inhibition by vascular endothelial growth factor receptor-2 blockade reduces stromal matrix metalloproteinase expression, normalizes stromal tissue, and reverts epithelial tumor phenotype in surface heterotransplants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010096

Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010096

Cellular internalization of poly(ethylene oxide)-b-poly(epsilon-caprolactone) diblock copolymer micelles

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010096

Size-controlled synthesis of magnetite nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010096

cRGD-functionalized polymer micelles for targeted doxorubicin delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010096

Three-dimensional MR mapping of angiogenesis with alpha5beta1(alpha nu beta3)-targeted theranostic nanoparticles in the MDA-MB-435 xenograft mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010096

Openings between defective endothelial cells explain tumor vessel leakiness

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010096

The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010096

Micellar hybrid nanoparticles for simultaneous magnetofluorescent imaging and drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010096

Theoretical MRI contrast model for exogenous T2 agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010096

A model for MRI contrast enhancement using T1 agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010096

Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.010096

21 January 2018

Identifiers

DOI

10.1258/EBM.2010.010096

1 reference

11 November 2017

1 reference